Formats
  1. Journal Article (66987)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3796)
  5. Editorial (2199)
  6. Conference Paper (1527)
  7. Correspondence (670)
  8. Guidelines (668)
  9. Research Letter (555)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39139)
  2. GSK Faculty (22507)
  3. Solid Tumor Oncology Division (22124)
  4. Surgery (21321)
  5. Survivorship Research (15802)
  6. Sloan Kettering Institute Faculty (15667)

More Groups

People
  1. Marc Ladanyi (1329)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2355)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5721)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2615)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13871)
  2. American Society of Clinical Oncology (9181)
  3. Springer (7204)
  4. Nature Publishing Group (6393)
  5. American Association for Cancer Research (6016)
  6. Elsevier Science, Inc. (5529)

More Publishers

Results (115824)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab
    Meeting Abstract

    Yu, Y.; Chen, L.; Riaz, N.; Kang, J.; Tsai, C. J.; Sherman, E. J.; Lee, N. Y.; McBride, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Rizvi, H.; DuBoff, M. A.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ladanyi, M.; Rimner, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Results of the PI3K delta inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL)
    Meeting Abstract

    Zelenetz, A. D.; Jagadeesh, D.; Reddy, N. M.; Stathis, A.; Salman, H. S.; Asch, A. S.; Kenkre, V. P.; Jhangiani, H. S.; Iasonos, A.; Soumerai, J. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)
    Meeting Abstract

    Zhang, T.; Ballman, K. V.; Choudhury, A. D.; Chen, R. C.; Watt, C.; Wen, Y.; Zemla, T.; Emamekhoo, H.; Gupta, S.; Morris, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001
    Meeting Abstract

    Garon, E. B.; Hellmann, M. D.; Costa, E. C.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Cutaneous eruption as a prognosis indicator for cancer patients treated with EGFR tyrosine kinase inhibitors: A systematic review and meta-analysis
    Meeting Abstract

    Wang, Y.; Wu, J.; Wang, S. Y.; Lacouture, M. E.; Wu, M.; Chung, W. H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition
    Meeting Abstract

    Weber, J. S.; Tang, H.; Hippeli, L.; Qian, M.; Wind-Rotolo, M.; Larkin, J. M. G.; Wolchok, J. D.; Sznol, M.; Robert, C.; Woods, D. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Whipple, S.; Martin, A.; Martinec, M.; Arbour, K. C.; Seshan, V. E.; Riely, G. J.; Crane, G.; Shen, R.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save